You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BBIO Sale Disclosure
Valantine Hannah · SEC Form 4 · Filed Jun 24, 2026
Sale
Calculated transaction value
$150.58K
Valantine Hannah Director
BBIO
BridgeBio Pharma
BBIO
Transaction date
Jun 23, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 1 day later
BBIO daily price context
Close on/before transaction
$68.63
Jun 23, 2026
First close after public filing
$69.69
Jun 25, 2026
30-day return after filing
+20.56%
Through Jul 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,196 shares @ $68.57
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-000635
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$458.7K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO Current | Sale | Jun 23, 2026 | $150.58K |
| Bridgebio Pharma, Inc. BBIO | Award | Jun 22, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO | Exercise | Jun 22, 2026 | $117.18K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 22, 2026 | $190.94K |
| Bridgebio Pharma, Inc. BBIO | Award | Jun 22, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO | Exercise | Jun 22, 2026 | $0 |